Candid Therapeutics, Inc, a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced an agreement...
BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, announced...
General Proximity, a breakthrough biotech platform company, announced its emergence from stealth, unveiling its proprietary OmniTAC platform designed to pioneer the next generation of...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
